Literature DB >> 6818593

Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect.

F Ferrari, G Baggio.   

Abstract

The influence of lisuride on naloxone-induced withdrawal signs (wet shakes, escape attempts) was studied in morphine-dependent rats. Lisuride, injected IP at doses of 12.5 and 25 micrograms/kg, inhibited wet shakes while not significantly altering escape attempts induced by naloxone (4 mg/kg IP). At higher doses (50 and 100 micrograms/kg IP), lisuride's inhibitory effect on wet shakes persisted while escape attempts were actually potentiated with respect to control withdrawal rats. Increases in aggressive behavior were seen at all doses, and were dose-related. Haloperidol (0.3 mg/kg IP), administered 40 min before lisuride, did not modify the antagonistic effect on wet shakes, unlike sulpiride (40 mg/kg IP 30 min before lisuride), but at the same time blocked the increase in escape attempts and aggressiveness induced by lisuride. We suggest that lisuride modulates withdrawal signs by stimulation of dopamine receptors in the CNS. The effect of the dopamine mimetic N-n-propylnorapomorphine (NPA) on the same variables is reported as well as the influence of haloperidol on NPA, and a comparison between the effects of the two drugs is made.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818593     DOI: 10.1007/bf00433735

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Effects of clonidine on morphine withdrawal signs in the rat.

Authors:  L F Tseng; H H Loh; E T Wei
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

2.  Blockade of morphine-withdrawal body shakes by haloperidol.

Authors:  H Lal; R Numan
Journal:  Life Sci       Date:  1976-01-15       Impact factor: 5.037

3.  Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.

Authors:  E T Iwamoto; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

4.  Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.

Authors:  A Herz; J Bläsig; R Papeschi
Journal:  Psychopharmacologia       Date:  1974

5.  The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice.

Authors:  Y Maruyama; A E Takemori
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

6.  Quantitative aspects of precipitated abstinence in morphine-dependent rats.

Authors:  E Wei; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

7.  Role of biogenic amines in morphine dependence in the rat.

Authors:  A S Schwartz; E Eidelberg
Journal:  Life Sci I       Date:  1970-06-01

8.  Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats.

Authors:  A Benassi-Benelli; F Ferrari; B P Quarantotti
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-12

9.  Role of brain dopaminergic mechanisms in rodent aggressive behavior: influence of (+/-)N-n-propyl-norapomorphine on three experimental models.

Authors:  G Baggio; F Ferrari
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.

Authors:  M Ary; B Cox; P Lomax
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

View more
  2 in total

Review 1.  The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior.

Authors:  Kimberly A Young; Kyle L Gobrogge; Zuoxin Wang
Journal:  Neurosci Biobehav Rev       Date:  2010-06-23       Impact factor: 8.989

2.  Influence of Selective Dopamine Agonist Ropinirole on Conditioned Place Preference and Somatic Signs of Morphine Withdrawal in Rats.

Authors:  Andleeb Shahzadi; Oruc Yunusoglu; Enes Karabulut; Haktan Sonmez; Zeliha Yazici
Journal:  Front Behav Neurosci       Date:  2022-06-06       Impact factor: 3.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.